These results, together with other epidemiological data, suggested that eNOS polymorphisms, other than the Glu298Asp, could play a role in influencing the onset and progression of vascular diseases, including CHD, HF and hypertension (Benjafield and Morris, 2000). The gene discussed is NOS3; the disease is coronary artery disorder.